Tolerability of enalapril initiation by patients with left ventricular dysfunction: results of the medication challenge phase of the Studies of Left Ventricular Dysfunction.
暂无分享,去创建一个
S. Yusuf | J. Kostis | J. Probstfield | C. Pepine | F. Delahaye | R. Capone | M. Weiss | G. Gosselin | L. Cahill | B. Shelton | C. J. Pepine | John B. Kostis | Jeffrey L. Probstfield | Robert J. Capone | Salim Yusuf | Gilbert Gosselin | Melvin B. Weiss | François Delahaye | Linda Cahill | Diana Dutton
[1] B. Pitt,et al. Effect of enalapril on myocardial infarction and unstable angina in patients with low ejection fractions , 1992, The Lancet.
[2] E. J. Brown,et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators. , 1992, The New England journal of medicine.
[3] S. Yusuf,et al. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. , 1992, The New England journal of medicine.
[4] W. Rogers,et al. Initial blood pressure response to enalapril in hospitalized patients (Studies of Left Ventricular Dysfunction [SOLVD]). , 1991, American Journal of Cardiology.
[5] Salim Yusuf,et al. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. , 1991, The New England journal of medicine.
[6] F. Tristani,et al. A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. , 1991, The New England journal of medicine.
[7] Salim Yusuf,et al. Studies of left ventricular dysfunction (SOLVD)--rationale, design and methods: two trials that evaluate the effect of enalapril in patients with reduced ejection fraction. , 1990, The American journal of cardiology.
[8] J. Kostis. Angiotensin converting enzyme inhibitors. II. Clinical use. , 1988, American heart journal.
[9] K. Swedberg,et al. Effects of enalapril on mortality in severe congestive heart failure: results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). , 1988, The American journal of cardiology.
[10] A. Crisp. 'Biological' depression; because sleep fails? , 1986, Postgraduate medical journal.
[11] S. Gottlieb,et al. Adverse effects of converting-enzyme inhibition in patients with severe congestive heart failure: pathophysiology and management. , 1986, Postgraduate medical journal.
[12] S. Ball,et al. Severe hypotension after first dose of enalapril in heart failure. , 1985, British medical journal.
[13] M. Wilén,et al. Effects of enalapril, a new angiotensin-converting enzyme inhibitor, in a controlled trial in heart failure. , 1985, Journal of the American College of Cardiology.
[14] D. Sharpe,et al. Enalapril in patients with chronic heart failure: a placebo-controlled, randomized, double-blind study. , 1984, Circulation.
[15] S. Textor,et al. Transient renal dysfunction during initial inhibition of converting enzyme in congestive heart failure. , 1984, British heart journal.
[16] M. Packer,et al. Hemodynamic patterns of response during long-term captopril therapy for severe chronic heart failure. , 1983, Circulation.
[17] E. Espiner,et al. Haemodynamic, hormonal, and electrolyte effects of enalapril in heart failure. , 1983, British heart journal.
[18] J. Halperin,et al. Angiotensin inhibition in severe heart failure: acute central and limb hemodynamic effects of captopril with observations on sustained oral therapy. , 1981, American heart journal.
[19] D. Mason,et al. Efficacy of oral angiotensin-converting enzyme inhibition with captopril therapy in severe chronic normotensive congestive heart failure. , 1981, American heart journal.
[20] J. Cohn,et al. Acute and Long‐term Response to an Oral Converting‐enzyme Inhibitor, Captopril, in Congestive Heart Failure , 1980, Circulation.
[21] N. Hollenberg,et al. Sustained effectiveness of converting-enzyme inhibition in patients with severe congestive heart failure. , 1980, The New England journal of medicine.
[22] B. Brundage,et al. Immediate and Sustained Hemodynamic and Clinical Improvement in Chronic Heart Failure by an Oral Angiotensin‐converting Enzyme Inhibitor , 1980, Circulation.
[23] T. Ryan,et al. Angiotensin Converting Enzyme Inhibition in Patients with Congestive Heart Failure , 1978, Circulation.